Market Overview

Jefferies Downgrades Caliper Life Sciences To Hold, Raises PT To $10.50


Jefferies & Company has downgraded Caliper Life Sciences (NASDAQ: CALP) from Buy to Hold and has raised the price target from $10 to $10.50.

Posted-In: Jefferies & CompanyDowngrades Price Target Analyst Ratings


Related Articles (CALP)

View Comments and Join the Discussion!

Latest Ratings

KSURaymond JamesReiterates188.0
WTRB of A SecuritiesDowngrades
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at